- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02745613
Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity (HIT)
January 28, 2020 updated by: Sudip Bajpeyi, University of Texas, El Paso
Does a Family History of Type 2 Diabetes Affect Exercise Induced Improvement in Insulin Sensitivity in a Hispanic Population?
This study investigates weather a family history of type 2 diabetes affects exercise induced improvements in insulin sensitivity in the hispanic population
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A family history of T2D (FH+) is a risk factor for developing insulin resistance (which precedes T2D) and T2D (Ryder et al., 2003).
Exercise training on the other hand has been shown to improve insulin sensitivity and is highly effective to prevent/manage T2D.
However it is not known if early signs of insulin resistance appear before being clinically diagnosed and if the benefits of exercise which prevent/cure T2D, are limited to the offspring of Hispanic T2D parents.
Therefore, the proposed study will determine 1) if normoglycemic (normal blood glucose) offspring of T2D parents are insulin resistant, using the gold standard method to measure insulin sensitivity and metabolic flexibility (ability to switch between carbohydrate and fat oxidation) 2) if 8 weeks of exercise training improves insulin sensitivity and metabolic flexibility to the same extent in FH+ compared to normoglycemic offspring of parents without any history of T2D (FH-) and 3) if 8 weeks of exercise training will change the blood, lipid and molecular profiles relevant to insulin sensitivity to same extent in FH+ compared to offspring of parents without family history of T2D (FH-).
Study Type
Interventional
Enrollment (Anticipated)
24
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Texas
-
El Paso, Texas, United States, 79968
- University of Texas at El Paso
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- 18 ≤ Age ≤ 40 years
- 18 ≤ BMI ≤ 30 kg/m2
- Both parents are Mexican/Mexican-American)
- Sedentary lifestyle
- Less than 60 minutes/wk. of structured exercise
- Physical activity level ≤ 1.4
Exclusion Criteria:
- Evidence of significant cardiovascular disease or diabetes
- A fasting blood glucose ≥100 mg/dL
- Screening blood pressure >140/90
- Hyperlipidemia
- Use of drugs affecting energy metabolism or body weight
- Excess alcohol, drug abuse, and smoking
- Eating disorder or eating attitudes interfering with study
- Unwillingness to be abide by randomization
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Family history of T2D
The participants will undergo 8 weeks of combined exercise
|
The subjects will undergo an 8 week combined exercise intervention
|
Experimental: No Family history of T2D
The participants will undergo 8 weeks of combined exercise
|
The subjects will undergo an 8 week combined exercise intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Insulin sensitivity
Time Frame: 8 weeks
|
8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Myokine concentrations
Time Frame: 8 weeks
|
8 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sudip Bajpeyi, PhD., University of Texas, El Paso
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2016
Primary Completion (Actual)
May 1, 2019
Study Completion (Actual)
May 1, 2019
Study Registration Dates
First Submitted
April 18, 2016
First Submitted That Met QC Criteria
April 19, 2016
First Posted (Estimate)
April 20, 2016
Study Record Updates
Last Update Posted (Actual)
January 30, 2020
Last Update Submitted That Met QC Criteria
January 28, 2020
Last Verified
January 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 755513-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Sensitivity/Resistance
-
Paloma Almeda-ValdésCompleted
-
University of Colorado, DenverRecruitingEndothelial Dysfunction | Vascular Stiffness | Insulin Sensitivity/Resistance | TransgenderismUnited States
-
University of Alabama at BirminghamNot yet recruitingCardiovascular Diseases | Obesity | Insulin Sensitivity/Resistance | Metabolic Disease | Energy Expenditure | MetabolismUnited States
-
Ingredion IncorporatedUnknownFocus of the Study is Insulin SensitivityUnited States
-
University Hospital TuebingenCompletedInsulin SensitivityGermany
-
University of CopenhagenCompleted
-
Marjukka KolehmainenKuopio University HospitalCompleted
-
Amsterdam UMC, location VUmcCompletedDiabetes Mellitus, Type 2 | Insulin Sensitivity/ResistanceNetherlands
-
Rigshospitalet, DenmarkUnknownInsulin Sensitivity and Lipid Metabolism
-
Garvan Institute of Medical ResearchThe University of Hong Kong; University of Sydney; The University of New South... and other collaboratorsCompletedObesity | Insulin Sensitivity/ResistanceAustralia
Clinical Trials on 8 weeks of combined exercise intervention
-
Nottingham Trent UniversityUniversity of ReadingRecruitingPhysical InactivityUnited Kingdom
-
Aarhus University HospitalUnknown
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)TerminatedMitochondrial Dysfunction in Type 2 Diabetes Mellitus and Capacity for Fat Oxidation During ExerciseDiabetes Mellitus, Type 2 | OverweightUnited States
-
Aarhus University Hospital SkejbyInstitute for Clinical and Experimental MedicineCompletedHeart Failure | Coronary Heart Disease | Ischemic Heart DiseasesDenmark
-
Hasselt UniversityJessa HospitalCompletedChronic Heart Failure
-
Central Jutland Regional HospitalAarhus University Hospital; University of Aarhus; VIA University CollegeWithdrawnPulmonary Embolism
-
VA Office of Research and DevelopmentCompletedHeart FailureUnited States
-
Universitätsklinikum Hamburg-EppendorfCharite University, Berlin, Germany; University Hospital Tuebingen; Technical... and other collaboratorsRecruitingFatigue | Malnutrition | Ovarian Cancer | Muscle WastingGermany
-
Seoul National University HospitalNot yet recruiting
-
Medical College of WisconsinChildren's Hospital and Health System Foundation, Wisconsin; Santosh Yoga LLCTerminated